Cyclin-Dependent Kinase 9 Inhibition as a Potential Treatment for Hepatocellular Carcinoma

YU-YUN SHAOHsu, Hung-WeiHung-WeiHsuWo, Rita RobinRita RobinWoWang, Han-YuHan-YuWangANN-LII CHENGCHIH-HUNG HSU2023-01-102023-01-10202200302414https://scholars.lib.ntu.edu.tw/handle/123456789/627095Composite cyclin-dependent kinase (CDK) inhibition has shown potential as a treatment for hepatocellular carcinoma (HCC) in preclinical studies. We tested whether the specific inhibition of CDK9 was effective against HCC.enApoptosis; Cell line; Cyclin; Cyclin-dependent kinase 9; Hepatocellular carcinoma; Myeloid cell leukemia-1; Orthotopic model; Preclinical study; RNA polymerase; Xenograft[SDGs]SDG3Cyclin-Dependent Kinase 9 Inhibition as a Potential Treatment for Hepatocellular Carcinomajournal article10.1159/000526978361038102-s2.0-85143196356https://api.elsevier.com/content/abstract/scopus_id/85143196356